activity
20172023
most citedA Review of Biomedical Datasets Relating to Drug Discovery: A Knowledge Graph Perspective

143 citations · 343 across the 8 of their papers we have counts for

collaborators

9 papers

q-bio.BM2023★ 37 cited

Utilizing Reinforcement Learning for de novo Drug Design

Hampus Gummesson Svensson, Christian Tyrchan, Ola Engkvist +1

Deep learning-based approaches for generating novel drug molecules with specific properties have gained a lot of interest in the last few years. Recent studies have demonstrated pr…

cs.LG2022★ 10 cited

Industry-Scale Orchestrated Federated Learning for Drug Discovery

Martijn Oldenhof, Gergely Ács, Balázs Pejó +44

To apply federated learning to drug discovery we developed a novel platform in the context of European Innovative Medicines Initiative (IMI) project MELLODDY (grant n°831472), whic…

cs.LG2022★ 4 cited

Autonomous Drug Design with Multi-Armed Bandits

Hampus Gummesson Svensson, Esben Jannik Bjerrum, Christian Tyrchan +2

Recent developments in artificial intelligence and automation support a new drug design paradigm: autonomous drug design. Under this paradigm, generative models can provide suggest…

cs.LG2021

Implications of Topological Imbalance for Representation Learning on Biomedical Knowledge Graphs

Stephen Bonner, Ufuk Kirik, Ola Engkvist +2

Adoption of recently developed methods from machine learning has given rise to creation of drug-discovery knowledge graphs (KG) that utilize the interconnected nature of the domain…

cs.CV2021

Parallel Capsule Networks for Classification of White Blood Cells

Juan P. Vigueras-Guillén, Arijit Patra, Ola Engkvist +1

Capsule Networks (CapsNets) is a machine learning architecture proposed to overcome some of the shortcomings of convolutional neural networks (CNNs). However, CapsNets have mainly…

q-bio.BM2021★ 66 cited

Understanding the Performance of Knowledge Graph Embeddings in Drug Discovery

Stephen Bonner, Ian P Barrett, Cheng Ye +4

Knowledge Graphs (KG) and associated Knowledge Graph Embedding (KGE) models have recently begun to be explored in the context of drug discovery and have the potential to assist in…

cs.AI2021★ 143 cited

A Review of Biomedical Datasets Relating to Drug Discovery: A Knowledge Graph Perspective

Stephen Bonner, Ian P Barrett, Cheng Ye +5

Drug discovery and development is a complex and costly process. Machine learning approaches are being investigated to help improve the effectiveness and speed of multiple stages of…

cs.LG2017★ 76 cited

Application of generative autoencoder in de novo molecular design

Thomas Blaschke, Marcus Olivecrona, Ola Engkvist +2

A major challenge in computational chemistry is the generation of novel molecular structures with desirable pharmacological and physiochemical properties. In this work, we investig…

cs.AI2017★ 7 cited

Molecular De Novo Design through Deep Reinforcement Learning

Marcus Olivecrona, Thomas Blaschke, Ola Engkvist +1

This work introduces a method to tune a sequence-based generative model for molecular de novo design that through augmented episodic likelihood can learn to generate structures wit…